TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 101 filers reported holding TANGO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $585,025 | +171.0% | 51,956 | -20.1% | 0.00% | – |
Q2 2023 | $215,916 | -45.2% | 65,035 | -34.8% | 0.00% | – |
Q1 2023 | $394,080 | -63.1% | 99,767 | -32.3% | 0.00% | – |
Q4 2022 | $1,068,505 | +207.0% | 147,380 | +53.3% | 0.00% | – |
Q3 2022 | $348,000 | -4.4% | 96,158 | +19.5% | 0.00% | – |
Q2 2022 | $364,000 | -39.9% | 80,444 | +0.7% | 0.00% | – |
Q1 2022 | $606,000 | -41.0% | 79,901 | -14.9% | 0.00% | – |
Q4 2021 | $1,027,000 | – | 93,878 | +312826.7% | 0.00% | – |
Q3 2021 | $0 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |